Intron A; Interferon Alfa-2B Recombinant, 10 million IU

<< >>
Description (Brief)
Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
Object consists of cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
Currently not on view
date made
product expiration date
Schering Corporation
place made
United States: New Jersey, Kenilworth
Physical Description
interferon alfa-2b recombinant (overall active ingredients)
glycine (overall ingredients)
sodium phosphate dibasic (overall ingredients)
paper (container material)
glass (container material)
overall: 8.8 cm x 6.2 cm x 3.5 cm; 3 7/16 in x 2 7/16 in x 1 3/8 in
bottles: 3.8 cm x 1.6 cm; 1 1/2 in x 5/8 in
small box: 8.2 cm x 3.1 cm x 3.2 cm; 3 7/32 in x 1 7/32 in x 1 1/4 in
ID Number
accession number
catalog number
Credit Line
Gift of Schering Corporation, through Steven Schneider, Vice-President
See more items in
Medicine and Science: Medicine
Recombinant Pharmaceuticals
Science & Mathematics
Biotechnology and Genetics
Health & Medicine
The Antibody Initiative
Antibody Initiative: Monoclonal Antibodies
Data Source
National Museum of American History


Add a comment about this object